Boothbay Fund Management’s Pfizer PFE Stock Holding History

Boothbay Fund Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-41,800	Closed	-$1.04M	–	2376
2025 Q4	$1.04M	Buy	+41,800	New	+$1.05M	0.02%	783
2024 Q3	–	Sell	-62,800	Closed	-$1.76M	–	1847
2024 Q2	$1.76M	Buy	+62,800	New	+$1.73M	0.04%	547
2023 Q4	–	Sell	-40,000	Closed	-$1.33M	–	1894
2023 Q3	$1.33M	Buy	+40,000	New	+$1.41M	0.03%	643
2023 Q1	–	Sell	-250,700	Closed	-$12.8M	–	2422
2022 Q4	$12.8M	Buy	250,700 +239,000	+2,043%	+$11.5M	0.3%	38
2022 Q3	$512K	Buy	11,700 +6,000	+105%	+$292K	0.01%	1217
2022 Q2	$299K	Sell	5,700 -13,900	-71%	-$708K	0.01%	1467
2022 Q1	$1.01M	Sell	19,600 -14,000	-42%	-$726K	0.02%	891
2021 Q4	$1.98M	Buy	+33,600	New	+$1.66M	0.05%	490
2021 Q1	–	Sell	-324	Closed	-$1.19M	–	1729
2020 Q4	$1.19M	Buy	324 +199	+159%	+$7.3K	0.04%	439
2020 Q3	$437K	Buy	+125	New	+$4.38K	0.03%	690
2018 Q2	–	Sell	-165	Closed	-$557K	–	861
2018 Q1	$557K	Buy	+165	New	+$5.67K	0.07%	298

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Boothbay Fund Management's PFE Position: Q1 2026 in Review

Boothbay Fund Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 12,127 shares — an estimated $302K sold.

Boothbay Fund Management first reported a position in PFE in Q4 2014 and held it in 18 quarters. The position peaked at $72.4M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Boothbay Fund Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
Boothbay Fund Management sold 12,127 Pfizer shares in Q1 2026, an estimated $302K.
Boothbay Fund Management first reported a position in Pfizer in Q4 2014 and held it in 18 quarters.
Boothbay Fund Management's Pfizer position peaked at $72.4M in Q4 2021.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.